Pds Biotechnology Corp
PDSB
Revenue
0.00
0.000.00%
-Assets
60.50M
▼-8.51M▼-12.33%
3 Months ChangeLiabilities
29.58M
▼-2.25M▼-7.06%
3 Months ChangeFree Cash Flow
-404.34k
▲10.46M▲96.28%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-02
Form 8-K
ID: 0001140361-24-042537
2024-09-16
Form 8-K
ID: 0001140361-24-041166
2024-09-16
Form 8-K
ID: 0001140361-24-041102
2024-08-13
Form 8-K
ID: 0001140361-24-037073
2024-08-13
Form 10-Q
ID: 0001140361-24-037067
2024-08-13
Form 8-K
ID: 0001140361-24-036940
2024-08-08
Form 8-K
ID: 0001140361-24-036288
2024-08-07
Form 8-K
ID: 0001140361-24-036026
2024-08-05
Form 8-K
ID: 0001140361-24-035618
2024-08-01
Form 8-K
ID: 0001140361-24-035211